Hacamat PERHİZİ 

                   Hacamat öncesi tavsiyeler

Hacamat olacak kişinin istirahatlı yani vücudunun dinlenmiş olması gerekir.

Hacamattan önce en az 3-4 saat bir şey yenmemesi gerekir.

Hacamattan bir gün evvel cima yapılmaması gerekir.

                Hacamat sonrası tavsiyeler

 Hacamat olduktan sonra bir yemek kaşığı doğal üzüm sirkesi ve üzerine bir bardak bal şerbeti içmek tavsiye olunur. (mümkünse)

Hacamat sonrası yağlı ve ağır gıdalar alınmamalı. Ciğer, et gibi

Hacamattan sonra iki gün  süt ürünleri yenmemeli ayrıca tuzlu ve acılı yiyeceklerden uzak durulmalı. Ayrıca Hacamattan sonra 3-4 saat uyumamalı  eğer hemen uyulursa hacamatın faydası eksilir..

Bol bol sebze ve meyve önerilir.

Medical Studies

Effect of cupping therapy in treating chronic headache and chronic back pain at "Al heijamah" clinic HMC
.........................................................................................................................

Dr. Mohamed M. Reslan Hssanien
(Reslan M.) Researcher of Complementary and Alternative Medicine( CAM) Outpatient Department.
Hamad General Hospital. Clinical associate, Primary Health Care Department Hamad Medical Corporation.

ABSTRACT

Objective : To test the effect of cupping therapy in treating chronic headache and chronic back pain.

Background: Cupping therapy "Al heijamah" is a very common non-conventional therapy in the Arabic societies that has been used in the treatment of a wide range of conditions, such as hypertension, rheumatic conditions, ranging from arthritis, sciatica and back pain, migraine, anxiety, and general physical and mental well-being.

Methods: This study was a clinical intervention (pre and post design) utilizing non- conventional therapy (AL Heijamah) for treatment of patients with chronic back pain or chronic headache, with three months follow up at the Out patients Department (OPD) of Hamad General Hospital (HGH) Hamad Medical Corporation (HMC), State of Qatar, from May 2007 to December 2007, to show the efficacy of that procedure on chronic pain using Visual Analog pain scale, pre and post intervention.

Results: The total number of the participants was eighty six, slightly more than half of them were male (51.2%). The majority were non Qatari (72.1%); thirty seven of them had headache and forty nine of them had back pain. Most of the participants were treated with wet cup therapy (98.8%) and only one of them was treated with dry cup. Fifty two of the participants had only one session of cupping while only five of them completed the four sessions. The pain score for patients with headache was decreased from eight to four after cupping therapy followed by intermittent periods of fluctuation of pain, scored from four to five for around five weeks, then it maintained constant at four score till the end of the follow up period. Meanwhile the pain scale for patients with low back pain decreased from seven to three after two weeks and stayed constant till the end of the twelve weeks.

Conclusion: The effect of cupping therapy (Al heijamah) for chronic headache and back pain has been studied and the results revealed significant improvements in participants as a result of cupping therapy. Further studies with larger samples, for longer duration of follow up and use of a comparison group are recommended.

Key words: Complementary, alternative medicine, cupping, heijamah.

Immunomodulatory Effects of Bloodletting Cupping Therapy in patients with Rheumatoid Arthritis

RA is a chronic inflammatory systemic disease that causes irreversible joint destruction. nGroup I – Conventionally Medicinally treatedn Group II – Combined treatment – Blood Letting Cupping every 4 weeks Conclusion:BLC combined with conventional therapy, exerts marked improvement on the clinical condition of the patient. Especially in the analogue of pain scale, reduces the laboratory markers of disease activity and it modulates the immune cellular conditions, particularly of innate immune response NK cell % and adaptive cellular immune response SIL-2R.

M.Ahmed Sahbaa et al – Egyptian Journal of Immunology

Vol.12 (2) 2005 – page 39-51